To news list
News 11.11.24

A new drug, Bempedoic acid, has been registered

Mir-Pharm Group announces successful registration of a new hypolipidemic agent - Bempedoic acid.

Moscow, November 2024


Bempedoic acid – ATP-citrate lyase inhibitor – the first oral hypolipidemic drug of a new class for lowering LDL-C levels – “not a statin”


  • used as monotherapy or in combination with other hypolipidemic drugs in patients with intolerance to statins or in patients for whom they are contraindicated¹
  • effectiveness has been studied in 4 multicenter, randomized, double-blind, placebo-controlled trials involving 3,623 adult patients¹
  • significantly reduces LDL-C, non-HDL-C, apoB, and CAC levels, both in monotherapy and in addition to the maximum tolerated dose of statins¹


¹ General characteristics of the medicinal product – Bempedoic acid RU No. LP-№(007155)-(РГ-RU) dated 08.10.2024

Other news

Please read our privacy policy

The present personal data processing policy is drawn up in accordance with the requirements of the Federal Law of July 27, 2006. No. 152-FЗ “On Personal Data” and determines the procedure for processing personal data and measures to ensure the security of personal data of Mir-Pharm LLC (hereinafter referred to as the Operator).

The operator sets as his most important goal and condition for the implementation of his activities the respect for the rights and freedoms of man and citizen in the processing of his personal data, including the protection of the rights to privacy, personal and family confidentiality.

The Operator's policy regarding the processing of personal data (hereinafter - the Policy) applies to all information that the Operator can receive about visitors of the website https://mirpharm.ru.

The user can get any clarification on issues of interest regarding the processing of his personal data by contacting the Operator via e-mail info@mirpharm.ru.

The current version of the Policy is located in free access on the Internet at https://mirpharm.ru/policy.

This document will reflect any changes in the policy of processing personal data by the Operator. The policy is valid indefinitely until it is replaced with a new version.

Read more